Skip to main content
. 2014 Jul 3;42(13):8343–8355. doi: 10.1093/nar/gku561

Figure 2.

Figure 2.

INXS knockdown in the non-tumor kidney cell line RC-124 reduces the BCL-XS/BCL-XL ratio. (A) INXS knockdown in the RC-124 cell line using two distinct INXS-knockdown ASOs (INXS-ASO-1 and -2) reduces by 60% the endogenous levels of INXS compared to a control scrambled oligonucleotide transfection. (B) The levels of BCL-XS (black) and BCL-XL (red) mRNA isoforms in the same cells were measured by RT-qPCR. (C) BCL-XS/BCL-XL mRNA ratio in these cells was significantly reduced from 0.25 to 0.15 upon transfection with INXS-ASO-1 and -2. The data are the mean ± SD of three independent experiments. *(P <0.05), and **(P<0.01).